Search the Newsreel

American Healthcare REIT (NYSE:AHR) Price Target Raised to $61.00 at Royal Bank Of Canada

Royal Bank of Canada has raised its price target for American Healthcare REIT (NYSE:AHR) to $61.00 from $56.00, maintaining an "outperform" rating, which suggests a 13.2% upside. This follows the company's strong quarterly performance, where it surpassed EPS and revenue expectations. Analysts generally hold …

Elanco Investors Fail to Revive Sales Misrepresentation Suit

The Seventh Circuit Court of Appeals has ruled against Elanco Animal Health Inc. investors, preventing them from proceeding with claims that the company misrepresented its sales. The court upheld the dismissal of the proposed class action, stating that the investors did not adequately allege …

Solas Capital discloses 7.1% SANUWAVE Health (SNWV) position via managed funds

Solas Capital Management, LLC and its portfolio manager Frederick Tucker Golden have reported a 7.1% beneficial ownership stake in SANUWAVE Health, Inc. (SNWV) through managed funds. This ownership amounts to 610,968 shares, held by two private funds and one sub-advised fund, granting them shared …

IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms

Shares of Incannex Healthcare (IXHL) experienced their best day in five months, jumping over 19% on Wednesday, driven by expectations of regaining Nasdaq compliance and upcoming regulatory discussions for its sleep apnea drug. The company implemented a 1-for-30 reverse stock split to help meet …

Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up Following Better-Than-Expected Earnings

Aveanna Healthcare (AVAH) shares gapped up after reporting better-than-expected earnings, with revenue rising 13.7% year over year to $670.5 million and adjusted EPS of $0.22, surpassing analyst estimates. The company also raised its 2026 guidance, projecting revenue above $2.68 billion and adjusted EBITDA above …

UnitedHealth Group Inc.: Target Price Consensus and Analysts Recommendations | UNH | US91324P1021

This article provides an overview of analyst recommendations and target price consensus for UnitedHealth Group Inc. (UNH). It details recent adjustments to price targets and ratings from various financial institutions like JPMorgan, Mizuho, and Morgan Stanley, largely maintaining or upgrading their outlooks. The consensus …

Is Privia Health Group (PRVA) A Bargain As Earnings Growth And Guidance Improve?

Armistice Capital (VSEE) reports 7.33% beneficial stake in VSee Health

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 7.33% in VSee Health, Inc., totaling 4,079,129 shares of common stock. The filing, a Schedule 13G/A, indicates shared voting and dispositive power over these shares, which are directly held by Armistice Capital …

T. Rowe Price Associates (EHC) discloses 5.1% Encompass Health stake on Schedule 13G

T. Rowe Price Associates has filed a Schedule 13G, disclosing a 5.1% beneficial ownership stake in Encompass Health Corp (EHC), totaling 5,056,225 common stock shares. The filing indicates that T. Rowe Price Associates holds sole voting power over 4,897,333 shares and sole dispositive power …

T. Rowe Price discloses 4.9% Guardant Health (GH) holding in 13G/A

T. Rowe Price Associates, Inc. has filed a Schedule 13G/A, disclosing a 4.9% beneficial ownership in Guardant Health, Inc. (GH) as of June 30, 2026. The firm holds 6,514,828 shares, with sole voting power over 6,359,951 shares and sole dispositive power over all 6,514,828 …

Sotera Health announces resignation of director James C. Neary

Sotera Health (NASDAQ:SHC) announced the resignation of James C. Neary from its Board of Directors, effective Thursday. The company clarified that his resignation was not due to any disagreements regarding its operations. This news follows Sotera Health's strong second-quarter financial results, where it surpassed …

MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside

MDxHealth SA's average stock price target has been reduced from $2.8 to $2.2 by analysts, with individual forecasts ranging from $1 to $4. This updated target suggests a potential upside of approximately 376% from its recent closing price. The consensus rating for the stock …

Hims & Hers Health raises 2023 revenue outlook after strong Q2 growth despite margin drop

Bausch Health Stock Gains Momentum as Stronger Earnings, Raised Outlook and Debt Progress Lift Investor Optimism

UBS Adjusts Price Target on Acadia Healthcare to $1.50 From $4.50, Keeps Neutral Rating

UBS has adjusted its price target for Acadia Healthcare (referred to as Accendra Health in the article) to $1.50, down from $4.50, while maintaining a Neutral rating on the stock. This adjustment follows similar downgrades and price target reductions from other firms like Citigroup …

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

Is American Healthcare REIT, Inc. (AHR) Outperforming Other Finance Stocks This Year?

The Finance group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is American Healthcare REIT (AHR) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the …

HCA Healthcare (HCA) Stock May Be 49% Undervalued As Wage Pressure Builds

HCA Healthcare (HCA) stock appears significantly undervalued according to both Discounted Cash Flow (DCF) and P/E ratio analyses, despite a 75.1% return over the past five years. The valuation gap could be influenced by recent concerns over rising labor costs, staffing pressures, and leadership …

Why Did Oscar Health (OSCR) Fall After Record Profit and a Guidance Hike?

Oscar Health, Inc. (NYSE:OSCR) shares closed 11.9% lower at $26.54 on August 6, even after the insurer reported its most profitable first half and raised its full-year outlook. Second-quarter revenue rose 70% year over year to $4.88 billion, while the company swung to net …

New Century Healthcare Flags Bank Account Freeze Linked to Partner Probe

Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?

Shares of Tenet Healthcare (THC) have been strong performers lately, with the stock up 34.1% over the past month. The stock hit a new 52-week high of $270.57 in the previous session. Tenet has gained 34.4% since the start of the year compared to …

AMN Healthcare Services (NYSE:AMN) Stock Price Expected to Rise, Citizens Jmp Analyst Says

Cohen & Steers (OHI) discloses 7.85% Omega Healthcare stake via 23.4M shares

Cohen & Steers, through its investment management subsidiaries, has disclosed a beneficial ownership of 23,382,961 shares of Omega Healthcare Investors, Inc. common stock, representing 7.85% of the class. The firm and its subsidiaries hold sole voting power over 18,559,089 shares and sole dispositive power …

Clover Health Is Proving Its Profit Model (NASDAQ:CLOV)

AlphaMena Upgrades Dallah Healthcare to Buy Rating

Zacks Research Cuts Earnings Estimates for Molina Healthcare

NewEdge Advisors LLC Buys 26,945 Shares of Omega Healthcare Investors, Inc. $OHI

NewEdge Advisors LLC significantly increased its stake in Omega Healthcare Investors (NYSE:OHI) by 81% in the first quarter, acquiring an additional 26,945 shares to bring its total holding to 60,190 shares, valued at $2.64 million. Omega Healthcare Investors reported strong Q1 earnings with EPS …

Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors?

agilon health (AGL) reported a significant profit rebound in Q2 2026, swinging from a net loss to a net income of US$17.96 million, and raised its full-year revenue guidance. This improvement, driven by better medical cost management rather than just top-line growth, suggests a …

Citizens raises Omada Health stock price target on revenue growth

Citizens has increased its price target for Omada Health Inc (OMDA) to $32.00 from $27.00, maintaining a Market Outperform rating, due to strong revenue growth and raised EBITDA estimates. The firm now projects 2026 revenue at $338 million and 2027 revenue at $395 million, …

National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

National Health Investors, Inc. (NYSE:NHI) has received a "Moderate Buy" consensus recommendation from eight brokerages, with an average 12-month price target of $83.86, significantly higher than its current share price of $71.23. The company also reported strong quarterly earnings of $1.19 EPS on $121.32 …

Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10.58 million to net income of US$28 million. Alongside this shift to profitability, the company …

USANA (USNA) Q2 2026 Earnings Call Transcript

Tenet Signs CAD$225M Minimum Guarantee Annual Services Agreement

Toronto, Ontario--(Newsfile Corp. - August 14, 2026) - Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet" or the "Company"), an innovative analytics service provider, owner and operator of the Cubeler Business Hub, today announced that it has signed an agreement with Sum …

Deutsche Bank Adjusts Aveanna Healthcare PT to $16 From $11.50, Maintains Buy Rating

Deutsche Bank has increased its price target for Aveanna Healthcare Holdings Inc. (AVAH) to $16 from $11.50, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook from the bank regarding the company's valuation. Earlier the same day, UBS also …

Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial

Fractyl Health is anticipating key data in Q4 for its Revita treatment, an endoscopic procedure aimed at preventing weight regain after GLP-1 assisted weight loss. The company is also launching a clinical trial for Rejuva, a gene therapy designed to induce pancreatic beta cells …

Numans Health Food Signals Higher Profit on Lower Revenue in Supplemental Alert